- Home
- JANX vs CMP Comparison
JANX vs CMP Comparison
Compare JANX & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JANX | CMP |
|---|---|---|
| Founded | 2017 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 890.8M | 1.0B |
| IPO Year | 2021 | 2003 |
Fundamental Metrics
Financial Performance| Metric | JANX | CMP |
|---|---|---|
| Price | $13.29 | $21.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $57.36 | $21.50 |
| AVG Volume (30 Days) | ★ 1.7M | 531.6K |
| Earning Date | 02-26-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $10,000,000.00 | ★ $1,332,800,000.00 |
| Revenue This Year | N/A | $0.25 |
| Revenue Next Year | N/A | $1.84 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 23.08 |
| 52 Week Low | $12.12 | $8.60 |
| 52 Week High | $44.83 | $27.00 |
Technical Indicators
Market Signals| Indicator | JANX | CMP |
|---|---|---|
| Relative Strength Index (RSI) | 36.48 | 40.01 |
| Support Level | $12.12 | $24.49 |
| Resistance Level | $14.16 | $27.00 |
| Average True Range (ATR) | 0.75 | 1.30 |
| MACD | 0.04 | -0.51 |
| Stochastic Oscillator | 17.66 | 2.50 |
Price Performance
Historical ComparisonAbout JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.